| Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations R Liu, X Wang, Y Shen, A He Molecular biology reports 48 (3), 2713-2727, 2021 | 22 | 2021 |
| PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6 Y Jia, X Yu, R Liu, L Shi, H Jin, D Yang, X Zhang, Y Shen, Y Feng, ... Cell Death & Disease 14 (8), 512, 2023 | 12 | 2023 |
| N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition R Liu, J Miao, Y Jia, G Kong, F Hong, F Li, M Zhai, R Zhang, J Liu, X Xu, ... Oncogene 42 (20), 1607-1619, 2023 | 10 | 2023 |
| Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies R Liu, D Gao, Y Lv, M Zhai, A He BMC endocrine disorders 22 (1), 29, 2022 | 9 | 2022 |
| Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial J Xu, BY Wang, SH Yu, SJ Chen, SS Yang, R Liu, LJ Chen, J Hou, Z Chen, ... Journal of Hematology & Oncology 17 (1), 23, 2024 | 7 | 2024 |
| A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma D Gao, R Liu, Y Lv, Y Feng, F Hong, X Xu, J Hu, A He, Y Yang Frontiers in Oncology 13, 999688, 2023 | 7 | 2023 |
| Comprehensive analysis of m6A RNA methylation regulators in the prognosis and immune microenvironment of multiple myeloma R Liu, Y Shen, J Hu, X Wang, D Wu, M Zhai, J Bai, A He Frontiers in Oncology 11, 731957, 2021 | 7 | 2021 |
| Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression R Liu, Y Jia, G Kong, A He Journal of Cancer Research and Clinical Oncology 148 (9), 2215-2230, 2022 | 5 | 2022 |
| A comprehensive analysis of coagulopathy during anti‐B cell maturation antigen chimeric antigen receptor‐T therapy in multiple myeloma, a retrospective study based on LEGEND‐2 R Liu, Y Lv, F Hong, W Zhao, B Lei, J Liu, W Zhang, A He, F Wang Hematological Oncology 41 (4), 704-717, 2023 | 4 | 2023 |
| Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 Axis F Li, J Liu, J Miao, F Hong, R Liu, Y Lv, Y Yang, A He, J Wang DNA and Cell Biology 43 (1), 39-55, 2024 | 3 | 2024 |
| Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia X Xu, R Liu, A He, F Wang Hematology 28 (1), 2265206, 2023 | 2 | 2023 |
| Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma Y Jia, R Liu, L Shi, Y Feng, L Zhang, N Guo, A He, G Kong BMC cancer 23 (1), 859, 2023 | 2 | 2023 |
| Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA‐specific CAR‐T therapy: a retrospective analysis of LEGEND‐2 R Liu, R Yang, X Xu, W Zhao, F Wang, W Zhang, B Lei, R Yang, Y Wang, ... British Journal of Haematology 204 (5), 1780-1789, 2024 | 1 | 2024 |
| Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia F Li, J Miao, R Liu, R Zhang, A He Journal of Cancer Research and Clinical Oncology 150 (3), 144, 2024 | 1 | 2024 |
| Circular RNA circXPO1 promotes multiple myeloma progression via sponging miR-495 3p and upregulating of DDIT4 F Li, J Liu, J Miao, F Hong, Y Lv, D Wu, Y Shen, R Liu, R Zhang, Y Jia, ... | 1 | 2022 |
| BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia R Zhang, J Miao, M Zhai, R Liu, F Li, X Xu, L Huang, T Wang, R Yang, ... Molecular Carcinogenesis 63 (6), 1146-1159, 2024 | | 2024 |
| KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway M Zhai, J Miao, R Zhang, R Liu, F Li, Y Shen, T Wang, X Xu, G Gao, J Hu, ... Journal of Cancer Research and Clinical Oncology 150 (5), 239, 2024 | | 2024 |
| Expression Status and Prognostic Roles of m6A-related Genes in Multiple Myeloma: YTHDF2 as the independent prognostic factor R Liu, Y Shen, X Wang, D Wu, M Zhai, A He, J Bai | | 2021 |
Jinsong HuDepartment of cell biology and genetics, Xi'an Jiaotong University Health Science Center在 xjtu.edu.cn 的电子邮件经过验证
